Lannett Prepares For Insulin Glargine Trial

Pivotal Clinical Trial For Biosimilar Lantus Rival Expected To Begin In March 2022

 
• By David Wallace
  
March 2022 calendar
Lannett will begin its pivotal trial in March 2022 • Source: Sergei Babenko / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products